Delivery Order SPE2DB22D3501-SPE2DB25FWN99
- Not listed
- The Defense Logistics Agency awarded a $1,750.20 delivery order to AmerisourceBergen Drug Corp for Atropine 1 mg/ml vials, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $16,471.67. The contract was competitively awarded without set-aside provisions and requires completion by June 9, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,799.30 to AmerisourceBergen Drug Corp for Atropine 0.4 mg/mL vials, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Atropine 1 mg/mL vials. This firm fixed price delivery order, valued at $1,339.21, represents a non-competitive award and is set to be completed by July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,074.04 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Atropine 1 mg/mL in vial form, with an ultimate completion date of September 18, 2025. This competitive award utilizes firm fixed-price pricing and carries no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,134.87 to AmerisourceBergen Drug Corp for Atropine 1 mg/mL vials, with an ultimate completion date of August 27, 2025. This is a firm fixed-price, non-set-aside contract executed on August 26, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical supplier to the federal...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,399.32 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/ml vials. This competitively awarded, firm fixed-price contract has no set-aside designation and was issued on August 6, 2025, with an ultimate completion date of August 7, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Atropine 1 mg/ml vials. This firm fixed-price delivery order, valued at $6,487.05, represents a non-competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,849.28 to AmerisourceBergen Drug Corp on July 22, 2025, for Atropine 0.4 mg/mL vials. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Atropine 1 mg/ml vials. This competitive, firm fixed-price delivery order has a ceiling value of $5,638.32 and an ultimate completion date of July 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWN99Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,397.77 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/ml vials. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 25, 2025. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with extensive experience fulfilling military and veteran healthcare requirements through the Defense Logistics Agency. As a major healthcare solutions provider, the company supplies a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. This particular delivery order for Atropine—a critical emergency medication used in military and medical contexts—exemplifies the company's role as a primary vendor for time-sensitive pharmaceutical needs within the federal supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/24/25 |